XBiotech

XBITNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$69.207 M

$2.27 -0.44%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$45.5M

Loss-making

Shares outstanding

30,487,731

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#331Citius OncologyCTOR$70.0M
#332Rein TherapeuticsRNTX$69.9M
#333XBiotechXBIT$69.2M
#334Inovio PharmaceuticalsINO$69.0M
#335Nomad Power SolutionsNMAD$68.3M

Where these numbers come from

Share counts and financials for XBiotech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.